John Patton

John Patton

Founder at
Aerami Therapeutics Holdings, Inc.
79 year
Health Technology
Consumer Services
Commercial Services

Profile

John Stuart Patton was the founder of Nektar Therapeutics, founded in 1990, where he held the title of Director & Chief Scientific Officer from 1990 to 2008.
He was also the founder of InCarda Therapeutics, Inc., founded in 2009, where he served as Chairman from 2009 to 2011.
Additionally, Dr. Patton is the founder of Aerami Therapeutics, Inc., founded in 2009, where he currently holds the title of Director.
Dr. Patton is also the founder of Aerami Therapeutics Holdings, Inc...
Dr. Patton's former jobs include being an Independent Director at Halozyme Therapeutics, Inc. from 1990 to 2015, a Director at Saegis Pharmaceuticals, Inc., a Director-Supervisory Board at Vectura GmbH from 2007 to 2014, and a Scientist at Genentech, Inc. in 1990.
He also held a position as a Professor at the University of Georgia.
In terms of education, Dr. Patton obtained a graduate degree from the University of Rhode Island, an undergraduate degree from The Pennsylvania State University, and a doctorate degree from the University of California San Diego.

John Patton active positions

CompaniesPositionStart
Founder -
Founder 01/01/2016

Former positions of John Patton

CompaniesPositionEnd
HALOZYME THERAPEUTICS, INC. Director/Board Member 06/05/2015
Director/Board Member 01/03/2014
Director/Board Member 17/02/2009
NEKTAR THERAPEUTICS Founder 21/11/2008
Chief Tech/Sci/R&D Officer 01/01/1990
See the detail of John Patton's experience

Training of John Patton

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!